Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Paliperidone ER in Adolescents with Schizophrenia
NCT00488319Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jun 2007
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Jun 2007; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00488319.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00488319.